Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

The company is carrying out a trial pitched at obtaining US Food and Drug Administration (FDA) approval for AFL, as well as a ...

The VT Symposium is hosted and coordinated by the Hospital at the University of Pennsylvania and Mount Sinai Hospital and focuses on new information and management strategies used for the care of ...

FULCRUM-VT (Feasibility of Ultra-Low Temperature Cryoablation in Recurring Monomorphic Ventricular Tachycardia, NCT05675865) is a prospective, multi-center, open-label, single-arm study ...

Holdings announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration FDA Pivotal ...

A new report issued Tuesday by third-party consultants says that as of last year, Vermont was spending $400 million to $460 million more on its schools than what it calls “adequate expenditure.” ...

with average highs in the 20s or 30s and average lows in the teens – but since Burlington is within easy driving distance of several Vermont ski resorts, winter is a popular time to visit.

1The Adagio Medical, Inc. VT Cryoablation System (Catheter and Console) is indicated for the treatment of monomorphic ventricular tachycardia by ablation of arrhythmogenic tissues that drive and ...

The Adagio Medical VT Cryoablation System with the vCLAS ... atrial flutter, and ventricular tachycardia. Certain statements in this press release may be considered “forward-looking statements ...

"Our center enrolled six patients in the Early Feasibility stage of FULCRUM-VT program, with encouraging results," said Dr. Stevenson, a world-renowned expert in the treatment of cardiac arrhythmias.

today announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System. Procedures were performed by ...